Zobrazeno 1 - 10
of 306
pro vyhledávání: '"Bizzaro, F"'
Autor:
Bizzaro, F, Falcetta, F, D’Agostini, E, Decio, A, Minoli, L, Erba, E, Peccatori, AF, Scanziani, E, Colombo, N, Zucchetti, M, Bani, MR, Ubezio, P, Giavazzi, R
Publikováno v:
International journal of cancer. 143(9)
The efficacy of therapeutic regimens incorporating weekly or every-3-weeks paclitaxel (PTX) for ovarian cancer is debated. We investigated the addition of bevacizumab in regimens of chemotherapy with different PTX doses and schedules in preclinical m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9df09917c71a94247d986aa04f7579b3
https://pubmed.ncbi.nlm.nih.gov/29752717
https://pubmed.ncbi.nlm.nih.gov/29752717
Autor:
Lupia M; Unit of Gynaecological Oncology Research, European Institute of Oncology IRCCS, Milan, Italy., Melocchi V; Unit of Cancer Biomarkers, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Bizzaro F; Laboratory of Tumor Metastasis Therapeutics, Istituto di Ricerche Farmacologiche Mario Negri-IRCCS, Milan, Italy., Lo Riso P; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy., Dama E; Unit of Cancer Biomarkers, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Baronio M; Unit of Gynaecological Oncology Research, European Institute of Oncology IRCCS, Milan, Italy., Ranghiero A; Pathology Unit, European Institute of Oncology IRCCS, Milan, Italy., Barberis M; Pathology Unit, European Institute of Oncology IRCCS, Milan, Italy., Bernard L; Clinical Genomics Lab, European Institute of Oncology IRCCS, Milan, Italy., Bertalot G; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy., Giavazzi R; Laboratory of Tumor Metastasis Therapeutics, Istituto di Ricerche Farmacologiche Mario Negri-IRCCS, Milan, Italy., Testa G; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Haemato-Oncology, University of Milan, Italy., Bianchi F; Unit of Cancer Biomarkers, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Cavallaro U; Unit of Gynaecological Oncology Research, European Institute of Oncology IRCCS, Milan, Italy.
Publikováno v:
International journal of cancer [Int J Cancer] 2022 Jul 15; Vol. 151 (2), pp. 240-254. Date of Electronic Publication: 2022 Mar 14.
Autor:
Fagoonee S; Department of Biological Sciences, Institute of Biostructure and Bioimaging, National Research Council, Molecular Biotechnology Center, Turin, Italy., Arigoni M; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy., Manco M; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy., Olivero M; Department of Oncology, University of Turin, Torino, Italy., Bizzaro F; Abich S.r.l., Biological and Chemical Analysis, Verbania, Italy., Magagnotti C; ProMeFa, Proteomics and Metabolomics Facility, IRCCS, San Raffaele Scientific Institute, Milan, Italy., Andolfo A; ProMeFa, Proteomics and Metabolomics Facility, IRCCS, San Raffaele Scientific Institute, Milan, Italy., Miniscalco B; Department of Veterinary Sciences, University of Turin, Italy., Forni M; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy., Todeschi S; Abich S.r.l., Biological and Chemical Analysis, Verbania, Italy., Tolosano E; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy., Bocchietto E; Abich S.r.l., Biological and Chemical Analysis, Verbania, Italy., Calogero R; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy., Altruda F; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy.
Publikováno v:
Antioxidants & redox signaling [Antioxid Redox Signal] 2022 Mar; Vol. 36 (7-9), pp. 480-504. Date of Electronic Publication: 2022 Jan 04.
Autor:
Bizzaro F; Laboratory of Cancer Metastasis Therapeutics, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy., Fuso Nerini I; Laboratory of Cancer Metastasis Therapeutics, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.; Laboratory of Cancer Pharmacology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Taylor MA; Early Oncology, AstraZeneca, Cambridge, UK., Anastasia A; Laboratory of Cancer Metastasis Therapeutics, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy., Russo M; Laboratory of Cancer Metastasis Therapeutics, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy., Damia G; Laboratory of Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy., Guffanti F; Laboratory of Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy., Guana F; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia Valenta, Biella, Italy., Ostano P; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia Valenta, Biella, Italy., Minoli L; Department of Veterinary Medicine, University of Milan, Milan, Italy., Hattersley MM; Early Oncology, AstraZeneca, Boston, USA., Arnold S; Early Oncology, AstraZeneca, Cambridge, UK., Ramos-Montoya A; Early Oncology, AstraZeneca, Cambridge, UK., Williamson SC; Early Oncology, AstraZeneca, Cambridge, UK., Galbiati A; Early Oncology, AstraZeneca, Cambridge, UK., Urosevic J; Early Oncology, AstraZeneca, Cambridge, UK., Leo E; Early Oncology, AstraZeneca, Cambridge, UK., Cavallaro U; Unit of Gynecological Oncology Research, Istituto Europeo di Oncologia IRCCS, Milan, Italy., Ghilardi C; Laboratory of Cancer Metastasis Therapeutics, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy., Barry ST; Early Oncology, AstraZeneca, Cambridge, UK., Bani MR; Laboratory of Cancer Metastasis Therapeutics, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy. mariarosa.bani@marionegri.it., Giavazzi R; Laboratory of Cancer Metastasis Therapeutics, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.
Publikováno v:
Journal of hematology & oncology [J Hematol Oncol] 2021 Nov 06; Vol. 14 (1), pp. 186. Date of Electronic Publication: 2021 Nov 06.
Autor:
Kouroumalis, Elias1 (AUTHOR) itsomidi@gmail.com, Tsomidis, Ioannis1 (AUTHOR), Voumvouraki, Argyro2 (AUTHOR) iro_voum@yahoo.gr
Publikováno v:
Viruses (1999-4915). Nov2024, Vol. 16 Issue 11, p1785. 43p.
Autor:
Moniot, Aurélie1 (AUTHOR), Schneider, Christophe2 (AUTHOR), Chardin, Laure3 (AUTHOR), Yaniz-Galende, Elisa3 (AUTHOR), Genestie, Catherine3 (AUTHOR), Etiennot, Marion1 (AUTHOR), Henry, Aubéri1 (AUTHOR), Drelon, Coralie2 (AUTHOR), Le Formal, Audrey3 (AUTHOR), Langlois, Benoit2 (AUTHOR), Venat, Laurence4 (AUTHOR), Louvet, Christophe5 (AUTHOR), Favier, Laure6 (AUTHOR), Lortholary, Alain7 (AUTHOR), Berton-Rigaud, Dominique8 (AUTHOR), Dohollou, Nadine9 (AUTHOR), Desauw, Christophe10 (AUTHOR), Fabbro, Michel11 (AUTHOR), Malaurie, Emmanuelle12 (AUTHOR), Dubot, Coraline13 (AUTHOR)
Publikováno v:
Molecular Cancer. 8/14/2024, Vol. 23 Issue 1, p1-17. 17p.
Autor:
Fagoonee, Sharmila1 sharmila.fagoonee@unito.it, Panella, Riccardo2,3,4,5
Publikováno v:
Minerva Biotechnology & Biomolecular Research. Dec2024, Vol. 36 Issue 4, p169-171. 3p.
Publikováno v:
In European Journal of Cancer July 2016 61 Supplement 1:S112-S112
Autor:
Bizzaro F; Laboratory of Biology and Treatment of Metastasis, Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy., Falcetta F; Laboratory of Anticancer Pharmacology, Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy., D'Agostini E; Laboratory of Biology and Treatment of Metastasis, Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy., Decio A; Laboratory of Biology and Treatment of Metastasis, Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy., Minoli L; Laboratory of Biology and Treatment of Metastasis, Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.; Department of Veterinary Medicine, University of Milan, Milan, Italy.; Mouse and Animal Pathology Lab (MAPLab), Fondazione Filarete, Milan, Italy., Erba E; Laboratory of Anticancer Pharmacology, Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy., Alessandro Peccatori F; University of Milano-Bicocca and Gynecologic Oncology Division, European Institute of Oncology, Milan, Italy., Scanziani E; Department of Veterinary Medicine, University of Milan, Milan, Italy., Colombo N; University of Milano-Bicocca and Gynecologic Oncology Division, European Institute of Oncology, Milan, Italy., Zucchetti M; Laboratory of Anticancer Pharmacology, Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy., Bani MR; Laboratory of Biology and Treatment of Metastasis, Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy., Ubezio P; Laboratory of Anticancer Pharmacology, Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy., Giavazzi R; Laboratory of Biology and Treatment of Metastasis, Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Publikováno v:
International journal of cancer [Int J Cancer] 2018 Nov 01; Vol. 143 (9), pp. 2187-2199. Date of Electronic Publication: 2018 Aug 07.
Autor:
Guffanti F; Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy., Fratelli M; Department of Biochemistry, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy., Ganzinelli M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bolis M; Department of Biochemistry, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy., Ricci F; Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy., Bizzaro F; Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy., Chilà R; Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy., Sina FP; Clinic of Obstetrics and Gynecology, San Gerardo Hospital, University of Milan-Bicocca, Department of Medicine and Surgery, Milan, Italy., Fruscio R; Clinic of Obstetrics and Gynecology, San Gerardo Hospital, University of Milan-Bicocca, Department of Medicine and Surgery, Milan, Italy., Lupia M; Unit of Gynecological Oncology Research, European Institute of Oncology, Milan, Italy., Cavallaro U; Unit of Gynecological Oncology Research, European Institute of Oncology, Milan, Italy., Cappelletti MR; Breast Cancer Unit and Translational Research Unit, ASST Cremona, Cremona, Italy., Generali D; Breast Cancer Unit and Translational Research Unit, ASST Cremona, Cremona, Italy.; Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, Italy., Giavazzi R; Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy., Damia G; Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Publikováno v:
Oncotarget [Oncotarget] 2018 May 15; Vol. 9 (37), pp. 24707-24717. Date of Electronic Publication: 2018 May 15 (Print Publication: 2018).